Tongji Hosptial affiliated to Tongji Medical college of Huazhong University of Science and Technology
Welcome,         Profile    Billing    Logout  
 22 Trials 
34 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Zheng rong
NCT05080322: Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis

Recruiting
4
150
RoW
Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray, Flixonase,H20140117, AZEP,H20150201, Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Flixonase,H20140117
Zheng Liu ENT, Wuhan Union Hospital, China, Zhongnan Hospital, The People's Hospital of Hebei Province
Allergic Rhinitis
12/24
01/25
SAST, NCT04088513: Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency

Recruiting
4
440
RoW
Aspirin, Acetylsalicylic acid, Clopidogrel, Plavix
First Affiliated Hospital, Sun Yat-Sen University
G6PD Deficiency, Stroke
12/24
12/24
NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Recruiting
3
477
RoW
transanal surgery, Miles surgery, Preoperative chemoradiotherapy
Zhang Rui
Almost-cCR, Surgery, Rectal Cancer
01/20
12/22
NCT06200766: A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis

Recruiting
3
640
RoW
Mometasone furoate as a nasal spray
Zheng Liu ENT, Zhejiang Xianju Pharma Tech. Co., Ltd
Seasonal Allergic Rhinitis
04/24
06/24
NCT06364904: An Phase III Study, Multicenter,Randomized Controlled Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

Not yet recruiting
3
210
RoW
Tislelizumab, Cisplatin, Gemcitabine and Trilaciclib, Tislelizumab, Cisplatin, Gemcitabine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Bladder Cancer
04/27
04/29
NCT05844150: A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC

Recruiting
2/3
445
RoW
PM8002, Platinum, Atezolizumab, Etoposide
Biotheus Inc.
SCLC
06/25
12/25
NCT06315426: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

Not yet recruiting
2
90
NA
GR1802 injection, Placebo
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Allergic Rhinitis
10/24
12/24
BGB-3111-2005-IIT, NCT05356858: An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

Recruiting
2
20
RoW
zanubrutinib
Xuanwu Hospital, Beijing
Neuromyelitis Optica
10/24
10/24
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Not yet recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
NCT06364956: Phase Ib/II Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma

Recruiting
1/2
36
RoW
Tislelizumab combined with two predefined dose groups of palbociclib, RP2D dose Of Tislelizumab combined with palbociclib was selected for phase II clinical trial.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Bladder Cancer
06/25
06/26
NCT05009134: Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination

Recruiting
N/A
120
RoW
There is no intervention in this study.
Huazhong University of Science and Technology, National Natural Science Foundation of China
Allergic Rhinitis, Allergen Immunotherapy, SARS-CoV-2
03/22
04/22
NCT05983003: Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data

Completed
N/A
3500
RoW
endoscopic sinus surgery, ESS
Zheng Liu
Chronic Sinusitis, Radiology, Pathology, Surgery, Progression
04/24
04/24
EMRESSECRS, NCT04852562: The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps

Recruiting
N/A
110
RoW
Modified radical endoscopic sinus surgery, MRESS, functional endoscopic sinus surgery, FESS
Zheng Liu
Chronic Sinusitis, Endoscopic Sinus Surgery, Nasal Polyps
12/23
12/24
NCT06198894: Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms

Recruiting
N/A
96
RoW
steroid-eluting sinus stent implant, BISORB bioabsorbable steroid-eluting sinus stent, Systemic glucocorticoids, Medrol, saline irrigations, 0.9% sodium chloride solution, Placebo, Systemic glucocorticoid placebo, sham procedure, In-office bilateral sham procedure of stent placement
Zheng Liu
Chronic Sinusitis
01/26
04/26
NCT06240104: Monitoring of Heart to Guide Myocardial Injury Patients to Wean From Ventilation

Recruiting
N/A
200
RoW
cardiac output index monitor
Peking University People's Hospital
Myocardial Ischaemia During Surgery
12/25
12/25
NCT06370468: The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis

Recruiting
N/A
150000
RoW
Epidemiological investigation
Zheng Liu ENT, Peking Union Medical College, Hainan People's Hospital, Shandong Second Provincial General Hospital, First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Xinjiang Medical University
Chronic Rhinitis
05/27
08/27
NCT06474923: Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face Recognition

Recruiting
N/A
1500
RoW
Face image and voice audio
Zheng Liu
Body Image, Speech Sound Disorder
12/24
06/25
NCT06462417: Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis

Not yet recruiting
N/A
15
RoW
Arbidol, Arbidol Hydrochloride
Zheng Liu, National Natural Science Foundation of China
Allergic Rhinitis
06/25
06/25
CATHEDRAL, NCT05134129: Correlation Between Targeted HbA1c Values and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After PCI

Recruiting
N/A
1500
RoW
Shanghai 10th People's Hospital
Diabetes Mellitus, Percutaneous Coronary Intervention
09/24
09/24
NCT05444491: Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer

Recruiting
N/A
1200
RoW
Singlera Genomics Inc., Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Colorectal Cancer
06/25
06/25
Wang, Nan
NCT06200766: A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis

Recruiting
3
640
RoW
Mometasone furoate as a nasal spray
Zheng Liu ENT, Zhejiang Xianju Pharma Tech. Co., Ltd
Seasonal Allergic Rhinitis
04/24
06/24
NCT06475417: Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer

Recruiting
2
42
RoW
Adebrelimab combined with DOS
Tang-Du Hospital, Jiangsu Hengrui Pharmaceutical Co., Ltd.
Gastric Cancer
05/25
04/26
SBRTLCES, NCT04274270: SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer

Not yet recruiting
N/A
60
RoW
Endostar, S1
Peking University Third Hospital, Mianyang Central Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Cancer Hospital, Peking University International Hospital, China-Japan Friendship Hospital, The fifth medical center of PLA general hospital, Second Hospital of Shanxi Medical University, Hiser Medical Center of Qingdao, Guangxi Ruikang Hospital, GEM flower hospital of Liaohe oil field, Tang-Du Hospital, Third Affiliated Hospital of Guizhou Medical University, Liuzhou Worker's Hospital, The Affiliated Hospital of Xuzhou Medical University, Dalian municipal central hospital affiliated of dalian medical university
Radiotherapy Side Effect
01/22
01/23
NCT06484764: Validate the Safety and Feasibility of the CT-guided Interventional Robot in Percutaneous Biopsy Procedure.

Completed
N/A
166
RoW
CT-fluoroscopy guided robot-assisted biopsy of thoracic and abdominal lesions, Freehand CT-guided percutaneous needle biopsy of thoracic and abdominal lesions
Tianjin Medical University Cancer Institute and Hospital, Tongji Hospital, The First Affiliated Hospital of Guangzhou Medical University, Wuhan United Imaging Healthcare-Surgical Technology Co., Ltd. Wuhan, China
Abdominal Cancer, Thoracic Cancer
10/23
11/23
NCT05715632: New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX

Recruiting
N/A
46
RoW
Carrelizumab combined with XELOX
Tang-Du Hospital
Gastric Cancer
03/24
03/25
NCT06370468: The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis

Recruiting
N/A
150000
RoW
Epidemiological investigation
Zheng Liu ENT, Peking Union Medical College, Hainan People's Hospital, Shandong Second Provincial General Hospital, First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Xinjiang Medical University
Chronic Rhinitis
05/27
08/27
NCT05418920: Clinical Trial of Reconstruction After Proximal Gastrectomy

Not yet recruiting
N/A
250
NA
left-opening single-flap technique, double-flap group technique
Oncogastroenterology Committee of Chinese, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, General Hospital of Ningxia Medical University, Henan Provincial People's Hospital, The First Affiliated Hospital of Shanxi Medical University
Esophagitis, Reflux
07/24
07/27
NCT05279612: Effect Analysis of Neoadjuvant Chemoradiotherapy Combined With Surgery in Laparoscope for Advanced Colon Cancer

Active, not recruiting
N/A
177
RoW
Short-term neoadjuvant chemoradiotherapy
Tang-Du Hospital
Colon Neoplasm
10/24
05/25
Zhu, Rongfei
NCT05080322: Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis

Recruiting
4
150
RoW
Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray, Flixonase,H20140117, AZEP,H20150201, Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Flixonase,H20140117
Zheng Liu ENT, Wuhan Union Hospital, China, Zhongnan Hospital, The People's Hospital of Hebei Province
Allergic Rhinitis
12/24
01/25
NCT05460325 / 2023-001105-31: A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)

Completed
3
20
RoW
Lanadelumab, SHP643, TAKHZYRO, TAK-743, DX-2930, Lanadelumab Injection
Takeda, Takeda
Hereditary Angioedema (HAE)
11/23
11/23
NCT06028490: A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis.

Recruiting
2
90
RoW
GR1802 injection-1, Xeligekimab, GR1802 injection-2, Placebo
Zheng Liu ENT
Allergic Rhinitis
11/23
11/23
NCT06228560: Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment

Recruiting
2
200
RoW
LP-003, Placebo, Omalizumab
Longbio Pharma
Chronic Spontaneous Urticaria
01/25
01/25
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Not yet recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
NCT06346899: A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

Recruiting
N/A
130
RoW
No intervention
Takeda
Hereditary Angioedema (HAE)
08/25
08/25

Download Options